Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Global Amyloid Mapping: Solving Amyloid Nucleation by Deep Mutagenesis

Project description

Decoding amyloid fibril formation

Protein misfolding leads to the formation of abnormal aggregates such as amyloid fibrils, which accumulate in tissues, disrupt normal cellular function and lead to various diseases such as Alzheimer's disease and Parkinson's disease. Funded by the European Research Council, the GLAM-Map project will follow a genomics approach to shed light on the aggregation rate of various proteins. Researchers will map the impact of mutations on amyloid nucleation and identify genomic sequences associated with amyloid formation. While obtaining fundamental insights into the process of amyloid fibril formation and disease prediction, the study also aims to guide the development of targeted therapeutics for amyloid diseases.

Objective

Amyloid fibrils form and precipitate in more than 50 incurable human diseases, including Alzheimer’s and Parkinson’s disease. All proteins may be able to form amyloids, at least under certain circumstances. However, aggregation is actually rare as the process of amyloid formation is controlled by a high kinetic barrier: protein sequences have to cross a free energy barrier to nucleate transition states which then seed irreversible fibril formation. Short-lived transition states are extremely challenging to study using biophysical methods. We have recently developed a massively parallel genomics approach to quantify the rate of aggregation of thousands of protein sequences. We also have evidence that, by quantifying the interactions between mutations, we can capture the key interactions between residues in the transition state. Here, we will unleash the potential of this approach by targeting the following aims:
1) Map the impact on amyloid nucleation of all possible mutations in >60 human and functional amyloids - generating reference atlases for clinical variant interpretation
2) Build an energetic and structural model of the transition state of disease-associated amyloids
3) Uncover sequences across the genome that nucleate amyloids in response to environmental stress
This project will uncover the rules required to understand, predict and engineer amyloid formation. By identifying the mutations that do and do not lead to amyloid formation, we will reveal which variants accelerate aggregation and cause disease. We will also address one of the most important questions in the field, i.e. identifying the interactions established in the transition states of amyloid nucleation, guiding the development of therapeutic approaches in amyloid diseases, including the worst kinds of dementia. Finally, our results will feed a new generation of models and predictors of protein aggregation to employ for disease variant interpretation and the synthetic design of novel proteins.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC - HORIZON ERC Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2023-COG

See all projects funded under this call

Host institution

FUNDACIO INSTITUT DE BIOENGINYERIA DE CATALUNYA
Net EU contribution
€ 1 999 008,00
Address
CARRER BALDIRI REIXAC PLANTA 2A 10-12
08028 Barcelona
Spain
Region
Este Cataluña Barcelona
Activity type
Research Organisations
Links
Total cost
€ 1 999 008,00

Beneficiaries (1)